Srra stock zacks
MARA Marathon Patent Group, Inc. — Stock Price and ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Sierra Oncology Inc (NASDAQ:SRRA) Given $74.00 Consensus ... Sierra Oncology Inc (NASDAQ:SRRA) has been assigned an average broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy rating. Brokerages have set a twelve-month consensus price objective of $74.00 for the […] Sierra Oncology Inc SRRA - Quotes, Financials, News ... Sierra Oncology Inc SRRA Overview. Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted
Sierra Oncology Stock Forecast: up to 13.180 USD! - SRRA ...
Historical index on US Stock Market : B "Should I invest in Sierra Oncology stock?" "Should I trade "SRRA" stock today?" According to our live Forecast System, Sierra Oncology, Inc stock is a very good long-term (1-year) investment*. "SRRA" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Sierra Oncology (NASDAQ:SRRA) Downgraded to “Sell” at ... Zacks Investment Research lowered shares of Sierra Oncology (NASDAQ:SRRA) from a hold rating to a sell rating in a research report sent to investors on Saturday, Zacks.com reports. According to Zacks, “Sierra Oncology, Inc. is a clinical-stage drug development company. It develops and markets drugs for the treatment of cancer. Sierra Oncology Sees Hammer Chart Pattern: Time to Buy? Jan 28, 2020 · Estimates have actually risen so much that the stock now has a Zacks Rank #1 (Strong Buy) suggesting this relatively unloved stock could be due for a breakout soon. This will be especially true if SRRA stock can build momentum from here and find a way to continue higher of off this encouraging trading development. SRRA Stock News - Fidelity
All of the latest stock splits, posted as they are announced, from The Online 1/ 16/2020 No SRRA 1 for 40 1/22/2020 1/22/2020 1/23/2020 Yes GURE 1 for 5
Zacks: Brokerages Expect Sierra Oncology Inc (NASDAQ:SRRA ...
Sierra Oncology (SRRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings. Sierra Oncology has been struggling lately, but the selling pressure may be coming to an end soon. Simply Wall St. Do Institutions Own Shares In Sierra Oncology
Oct 28, 2019 · SRRA, Sierra Oncology Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines SRRA - Sierra Oncology, Inc. Summary, Stock ... - Benzinga Jan 01, 2010 · Trade SRRA stock for free with recommended broker TD Ameritrade. Abingworth Discloses 9.9% Advice Stake In Sierra Oncology Benzinga Newsdesk Mon, (SRRA) Zacks Feb 26, 2020; Sierra Oncology, Inc. Common Stock (SRRA) Real-Time Stock ... SRRA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low SRRA - Sierra Oncology Stock Price - Barchart.com
Zacks Investment Research lowered shares of Sierra Oncology (NASDAQ:SRRA) from a hold rating to a sell rating in a research note released on Saturday morning, Zacks.com reports. According to Zacks
Sierra Oncology +10% premarket on launching late-stage ... Nov 20, 2019 · Sierra Oncology (NASDAQ:SRRA) has launched the MOMENTUM clinical trial for patients with myelofibrosis.The Phase 3 trial is designed to confirm the efficacy of …
Shares of Sierra Oncology Inc (NASDAQ:SRRA) have received an average broker rating score of 1.00 (Strong Buy) from the two brokers that cover the stock, Zacks Investment Research reports. Two investment analysts have rated the stock with a strong buy rating. Brokers have set a one year consensus target price of $74.00 for the company […] SRRA Sierra Oncology Inc — Stock Price and ... - StockTwits Apr 03, 2020 · Real-time trade and investing ideas on Sierra Oncology Inc SRRA from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. SRRA | Sierra Oncology Inc. Profile | MarketWatch Nov 05, 2019 · Sierra Oncology Inc. company facts, information and stock details by MarketWatch. View srra business summary and other industry information.